Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1979 1
1984 1
1985 2
1986 3
1987 1
1988 3
1989 6
1990 1
1991 3
1992 2
1993 13
1994 2
1995 2
1996 6
1997 10
1998 8
1999 6
2000 8
2001 6
2002 8
2003 5
2004 5
2005 6
2006 11
2007 6
2008 7
2009 8
2010 10
2011 11
2012 9
2013 10
2014 10
2015 14
2016 18
2017 21
2018 22
2019 17
2020 15
2021 17
2022 22
2023 13
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

314 results

Results by year

Filters applied: . Clear all
Page 1
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.
Linton KM, Vitolo U, Jurczak W, Lugtenburg PJ, Gyan E, Sureda A, Christensen JH, Hess B, Tilly H, Cordoba R, Lewis DJ, Okada C, Hutchings M, Clausen MR, Sancho JM, Cochrane T, Leppä S, Chamuleau MED, Gernhardt D, Altıntaş I, Liu Y, Ahmadi T, Dinh MH, Hoehn D, Favaro E, Elliott B, Thieblemont C, Vose JM. Linton KM, et al. Among authors: sancho jm. Lancet Haematol. 2024 Aug;11(8):e593-e605. doi: 10.1016/S2352-3026(24)00166-2. Epub 2024 Jun 15. Lancet Haematol. 2024. PMID: 38889737 Clinical Trial.
[Plasmablastic lymphoma].
Fernández-Álvarez R, Sancho JM, Ribera JM. Fernández-Álvarez R, et al. Among authors: sancho jm. Med Clin (Barc). 2016 Nov 4;147(9):399-404. doi: 10.1016/j.medcli.2016.06.036. Epub 2016 Aug 28. Med Clin (Barc). 2016. PMID: 27576534 Review. Spanish.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.
Hess G, Dreyling M, Oberic L, Gine E, Zinzani PL, Linton K, Vilmar A, Jerkeman M, Chen JMH, Ohler A, Stilgenbauer S, Thieblemont C, Lambert J, Zilioli VR, Sancho JM, Jiménez-Ubieto A, Fischer L, Eyre TA, Keeping S, Park JE, Wu JJ, Siddiqi R, Reitan J, Wade S, Salles G. Hess G, et al. Among authors: sancho jm. Br J Haematol. 2023 Aug;202(4):749-759. doi: 10.1111/bjh.18519. Epub 2022 Oct 18. Br J Haematol. 2023. PMID: 36257914 Free PMC article.
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial.
Kalakonda N, Maerevoet M, Cavallo F, Follows G, Goy A, Vermaat JSP, Casasnovas O, Hamad N, Zijlstra JM, Bakhshi S, Bouabdallah R, Choquet S, Gurion R, Hill B, Jaeger U, Sancho JM, Schuster M, Thieblemont C, De la Cruz F, Egyed M, Mishra S, Offner F, Vassilakopoulos TP, Warzocha K, McCarthy D, Ma X, Corona K, Saint-Martin JR, Chang H, Landesman Y, Joshi A, Wang H, Shah J, Shacham S, Kauffman M, Van Den Neste E, Canales MA. Kalakonda N, et al. Among authors: sancho jm. Lancet Haematol. 2020 Jul;7(7):e511-e522. doi: 10.1016/S2352-3026(20)30120-4. Lancet Haematol. 2020. PMID: 32589977 Free article. Clinical Trial.
Treatment of localized-stage follicular lymphoma.
Sorigue M, Tuset V, Sancho JM. Sorigue M, et al. Among authors: sancho jm. Eur J Haematol. 2018 May 12. doi: 10.1111/ejh.13093. Online ahead of print. Eur J Haematol. 2018. PMID: 29754401 Review.
Recent landmark studies in follicular lymphoma.
Sorigue M, Sancho JM. Sorigue M, et al. Among authors: sancho jm. Blood Rev. 2019 May;35:68-80. doi: 10.1016/j.blre.2019.03.006. Epub 2019 Mar 23. Blood Rev. 2019. PMID: 30928169 Review.
New drugs for follicular lymphoma.
Sorigue M, Ribera JM, Motlló C, Sancho JM. Sorigue M, et al. Among authors: sancho jm. Leuk Res. 2016 Oct;49:38-46. doi: 10.1016/j.leukres.2016.08.004. Epub 2016 Aug 10. Leuk Res. 2016. PMID: 27541051 Review.
Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.
Hess G, Dreyling M, Oberic L, Gine E, Zinzani PL, Linton K, Vilmar A, Jerkeman M, Chen JMH, Ohler A, Stilgenbauer S, Thieblemont C, Lambert J, Zilioli VR, Sancho JM, Jimenez-Ubieto A, Fischer L, Eyre TA, Keeping S, Park JE, Wu JJ, Nunes A, Reitan J, Wade SW, Salles G. Hess G, et al. Among authors: sancho jm. Leuk Lymphoma. 2024 Jan;65(1):14-25. doi: 10.1080/10428194.2023.2268228. Epub 2024 Jan 10. Leuk Lymphoma. 2024. PMID: 37840282
The lymphocyte-to-monocyte ratio in follicular lymphoma.
Sorigue M, Sancho JM. Sorigue M, et al. Among authors: sancho jm. Leuk Lymphoma. 2021 Oct;62(10):2558-2561. doi: 10.1080/10428194.2021.1929965. Epub 2021 Jun 8. Leuk Lymphoma. 2021. PMID: 34100677 No abstract available.
314 results